Published 2025-02-01
“…We based our analysis on pharmacologically active SHL components we previously identified through untargeted metabolomics profiling. Key
cheminformatics and bioinformatics platforms and databases, including ADMETlab, SEA, PASS, Super-Pred, SwissTargetPrediction, PharmMapper, and GeneCards, were used to predict the drug-like properties of active SHL components and identify protein targets shared between the active SHL components and the URTI-related disease genes. …”
Get full text
Article